Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001726100-20-000001
Filing Date
2020-11-16
Accepted
2020-11-16 13:34:00
Documents
1
Effectiveness Date
2020-11-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8728
  Complete submission text file 0001726100-20-000001.txt   9772
Mailing Address 9000 CROW CANYON ROAD, STE. 620 DANVILLE CA 94506
Business Address 9000 CROW CANYON ROAD, STE. 620 DANVILLE CA 94506 (925) 399-7246
Elysium Therapeutics, Inc. (Filer) CIK: 0001726100 (see all company filings)

EIN.: 462769808 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-380638 | Film No.: 201315277